OMB Individually Reported

Xeleris V

High riskExact public inventory row

Description

Xeleris V AI-enabled clinical applications provide an accurate, efficient, and reproducible way to segment organs. AI-enabled clinical applications have the potential to greatly improve efficiency and precision in nuclear oncology.

Detailed example

Automated segmentation and dosimetry recommendations.

AI / analytics pattern

Computer Vision: AI that processes and interprets visual data (e.g., images and videos).

Automation level / stage

c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.

Expected benefit

Xeleris V leverages AI to accurately segment organs for quantitation and dosimetry calculations. The AI demonstrated a 58% average reduction in the time required for the user to process and calculate the dose. This AI-enabled lung segmentation demonstrated an overall success rate of 89% and reduction in the number of clicks by an average 57%.

Controls / human review

ATO: Not reported; PIA: Not published